Patents by Inventor Jeff Galvin

Jeff Galvin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • HIV pre-immunization and immunotherapy
    Patent number: 11612649
    Abstract: The present invention relates generally to immunization and immunotherapy for the treatment or prevention of HIV. In particular, the methods include in vivo and/or ex vivo enrichment of HIV-specific CD4+ T cells.
    Type: Grant
    Filed: February 12, 2021
    Date of Patent: March 28, 2023
    Assignee: American Gene Technologies International Inc.
    Inventors: Charles David Pauza, Haishan Li, Tyler Lahusen, Jeff Galvin
  • HIV PRE-IMMUNIZATION AND IMMUNOTHERAPY
    Publication number: 20210330783
    Abstract: The present invention relates generally to immunization and immunotherapy for the treatment or prevention of HIV. In particular, the methods include in vivo and/or ex vivo enrichment of HIV-specific CD4+ T cells.
    Type: Application
    Filed: February 12, 2021
    Publication date: October 28, 2021
    Inventors: Charles David Pauza, Haishan Li, Tyler Lahusen, Jeff Galvin
  • HIV pre-immunization and immunotherapy
    Patent number: 11090379
    Abstract: The present invention relates generally to immunization and immunotherapy for the treatment or prevention of HIV. In particular, the methods include in vivo and/or ex vivo enrichment of HIV-specific CD4+ T cells.
    Type: Grant
    Filed: October 4, 2019
    Date of Patent: August 17, 2021
    Assignee: American Gene Technologies International Inc.
    Inventors: Charles David Pauza, Haishan Li, Tyler Lahusen, Jeff Galvin
  • HIV PRE-IMMUNIZATION AND IMMUNOTHERAPY
    Publication number: 20200109417
    Abstract: The present invention relates generally to immunization and immunotherapy for the treatment or prevention of HIV. In particular, the methods include in vivo and/or ex vivo enrichment of HIV-specific CD4+ T cells.
    Type: Application
    Filed: October 4, 2019
    Publication date: April 9, 2020
    Inventors: Charles David Pauza, Haishan Li, Tyler Lahusen, Jeff Galvin
  • HIV pre-immunization and immunotherapy
    Patent number: 10494647
    Abstract: The present invention relates generally to immunization and immunotherapy for the treatment or prevention of HIV. In particular, the methods include in vivo and/or ex vivo enrichment of HIV-specific CD4+ T cells.
    Type: Grant
    Filed: December 12, 2018
    Date of Patent: December 3, 2019
    Assignee: American Gene Technologies International Inc.
    Inventors: Charles David Pauza, Haishan Li, Tyler Lahusen, Jeff Galvin
  • HIV PRE-IMMUNIZATION AND IMMUNOTHERAPY
    Publication number: 20190218573
    Abstract: The present invention relates generally to immunization and immunotherapy for the treatment or prevention of HIV. In particular, the methods include in vivo and/or ex vivo enrichment of HIV-specific CD4+ T cells.
    Type: Application
    Filed: December 12, 2018
    Publication date: July 18, 2019
    Inventors: Charles David Pauza, Haishan Li, Tyler Lahusen, Jeff Galvin
  • HIV pre-immunization and immunotherapy
    Patent number: 10233464
    Abstract: The present invention relates generally to immunization and immunotherapy for the treatment or prevention of HIV. In particular, the methods include in vivo and/or ex vivo enrichment of HIV-specific CD4+ T cells.
    Type: Grant
    Filed: June 18, 2018
    Date of Patent: March 19, 2019
    Assignee: American Gene Technologies International Inc.
    Inventors: Charles David Pauza, Haishan Li, Tyler Lahusen, Jeff Galvin
  • HIV PRE-IMMUNIZATION AND IMMUNOTHERAPY
    Publication number: 20180291399
    Abstract: The present invention relates generally to immunization and immunotherapy for the treatment or prevention of HIV. In particular, the methods include in vivo and/or ex vivo enrichment of HIV-specific CD4+ T cells.
    Type: Application
    Filed: June 18, 2018
    Publication date: October 11, 2018
    Inventors: Charles David Pauza, Haishan Li, Tyler Lahusen, Jeff Galvin
  • HIV pre-immunization and immunotherapy
    Patent number: 10036038
    Abstract: The present invention relates generally to immunization and immunotherapy for the treatment or prevention of HIV. In particular, the methods include in vivo and/or ex vivo enrichment of HIV-specific CD4+ T cells.
    Type: Grant
    Filed: August 3, 2017
    Date of Patent: July 31, 2018
    Assignee: American Gene Technologies International Inc.
    Inventors: Charles David Pauza, Haishan Li, Tyler Lahusen, Jeff Galvin
  • Protective feedthrough
    Patent number: 5759197
    Abstract: A feedthrough configuration for a hermetically sealed implantable medical device includes a metal case having an aperture and a feedthrough in the aperture which includes a ferrule sealed in the aperture, a pin extending through the ferrule and the aperture, an insulating material supporting the pin within the ferrule and an electrically conductive block spaced from the ferrule and in electrical connection with the pin. A device for electrical or electromagnetic protection can be connected to a peripheral upstanding portion of the ferrule and a peripheral skirt portion of the block. This arrangement of feedthrough elements can be particularly useful if the protective device is a chip capacitor which typically has a flat-sided configuration that can bridge the space between the ferrule and the block and be connected at one end to the block and at the other end to the ferrule.
    Type: Grant
    Filed: October 30, 1995
    Date of Patent: June 2, 1998
    Assignee: Medtronic, Inc.
    Inventors: Robert T. Sawchuk, Lynn M. Seifried, Bill Simmons, Jeff Galvin, David Ruben